FDA to Expand High Performance Computing to Boost Clinical Trial Efficiency

Clinical Trials Advisor
A A
The FDA plans to expand its capabilities in high performance computing to help build disease models and simulate clinical trials, as part of an agency “innovation initiative” announced July 7 by Commissioner Scott Gottlieb.

To View This Article:

Login

Subscribe To Clinical Trials Advisor